Next-generation sequencing (NGS)
NGS analysis was performed on nasopharyngeal samples with RNA titers ≥ 600 copies/mL on Days 1 and 5 and on post-treatment nasopharyngeal samples with RNA titers ≥ 100,000 copies/mL on Days 10, 15, and 29. All NGS analyses were performed by Q